Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-000163
Filing Date
2023-01-09
Accepted
2023-01-09 17:28:59
Documents
68
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20221130x10q.htm   iXBRL 10-Q 2145108
2 EX-10.2 cydy-20221130xex10d2.htm EX-10.2 88614
3 EX-10.3 cydy-20221130xex10d3.htm EX-10.3 138929
4 EX-10.4 cydy-20221130xex10d4.htm EX-10.4 183422
5 EX-31.1 cydy-20221130xex31d1.htm EX-31.1 9270
6 EX-31.2 cydy-20221130xex31d2.htm EX-31.2 9435
7 EX-32 cydy-20221130xex32.htm EX-32 6427
  Complete submission text file 0001558370-23-000163.txt   9002053

Data Files

Seq Description Document Type Size
8 EX-101.SCH cydy-20221130.xsd EX-101.SCH 71795
9 EX-101.CAL cydy-20221130_cal.xml EX-101.CAL 56714
10 EX-101.DEF cydy-20221130_def.xml EX-101.DEF 278731
11 EX-101.LAB cydy-20221130_lab.xml EX-101.LAB 470946
12 EX-101.PRE cydy-20221130_pre.xml EX-101.PRE 432875
62 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20221130x10q_htm.xml XML 1411208
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 23519020
SIC: 2834 Pharmaceutical Preparations